IP Library › Granted Patent US 11,467,425
Granted Patent B2
US 11,467,425 · App. 16/984,301 · Granted Oct 11, 2022

Contact lens product

Inventors: En-Ping Lin (Taichung, TW); Wei-Yuan Chen (Taichung, TW); Chun-Hung Teng (Taichung, TW)
Assignee: LARGAN MEDICAL CO., LTD.
G02C7/049G02C7/04G02C7/041G02C7/042G02C7/044G02C2202/06G02C2202/22G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,467,425
App. No.
16/984,301
Granted
Oct 11, 2022
Kind
B2
Abstract

A contact lens product includes a multifocal contact lens and a buffer solution. The multifocal contact lens includes a central region and at least one annular region. The annular region concentrically surrounds the central region. A diopter of the annular region is different from a diopter of the central region. The multifocal contact lens is immersed in the buffer solution, and the buffer solution includes a cycloplegic agent.

Claims (23)

1. A contact lens product, comprising:

a multifocal contact lens made of hydrogel, comprising:

a central region; and

at least one annular region concentrically surrounding the central region, wherein a diopter of the annular region is different from a diopter of the central region, and the annular region closest to a periphery of the multifocal contact lens is a first annular region; and

a buffer solution, wherein the multifocal contact lens is immersed in the buffer solution, and the buffer solution comprises a cycloplegic agent;

wherein a composition for manufacturing the hydrogel comprises 2-hydroxyethyl methacrylate and methacrylic acid, a weight percentage concentration of the 2-hydroxyethyl methacrylate in the composition for manufacturing the hydrogel is 10% to 96%, and a weight percentage concentration of the methacrylic acid in the composition for manufacturing the hydrogel is 0.01% to 5%;

wherein a diopter of the central region of the multifocal contact lens is PowC, a maximum diopter of the first annular region of the multifocal contact lens is PowP1, a diameter of the central region of the multifocal contact lens is DiC, a weight percentage concentration of the cycloplegic agent in the buffer solution is ConA, and the following conditions are satisfied:

2.50 D≤PowP1−PowC;

4 mm<DiC≤9 mm; and

0.01%<ConA<0.5%.

2. The contact lens product of claim 1 , wherein the weight percentage concentration of the cycloplegic agent in the buffer solution is ConA, and the following condition is satisfied:

0.01%<ConA≤0.25%.

3. The contact lens product of claim 2 , wherein the weight percentage concentration of the cycloplegic agent in the buffer solution is ConA, and the following condition is satisfied:

0.05%≤ConA≤0.25%.

4. The contact lens product of claim 1 , wherein a composition for manufacturing the multifocal contact lens comprises a blue-light blocking agent, and the blue-light blocking agent is 4-(phenyldiazenyl) phenyl methacrylate.

5. The contact lens product of claim 1 , wherein the composition for manufacturing the hydrogel further comprises 1,1,1-trimethylol propane trimethacrylate, and a weight percentage concentration of the 1,1,1-trimethylol propane trimethacrylate in the composition for manufacturing the hydrogel is 0.01% to 5%.

6. The contact lens product of claim 5 , wherein the composition for manufacturing the hydrogel further comprises ethylene glycol dimethacrylate, and a weight percentage concentration of the ethylene glycol dimethacrylate in the composition for manufacturing the hydrogel is 0.01% to 5%.

7. The contact lens product of claim 6 , wherein the composition for manufacturing the hydrogel further comprises glycerol, and a weight percentage concentration of the glycerol in the composition for manufacturing the hydrogel is 0.1% to 30%.

8. The contact lens product of claim 7 , wherein the composition for manufacturing the hydrogel further comprises 2-hydroxy-2-methyl-propiophenone, and a weight percentage concentration of the 2-hydroxy-2-methyl-propiophenone in the composition for manufacturing the hydrogel is 0.01% to 5%.

9. The contact lens product of claim 8 , wherein the composition for manufacturing the hydrogel further comprises 2-(2′-Hydroxy-5′-methacryloxyethylphenyl)-2H-benzotriazole, and a weight percentage concentration of the 2-(2′-Hydroxy-5′-methacryloxyethylphenyl)-2H-benzotriazole in the composition for manufacturing the hydrogel is 0.01% to 10%.

10. The contact lens product of claim 8 , wherein the composition for manufacturing the hydrogel further comprises 2-(4-Benzoyl-3-hydroxyphenoxy) ethyl acrylate, and a weight percentage concentration of the 2-(4-Benzoyl-3-hydroxyphenoxy) ethyl acrylate in the composition for manufacturing the hydrogel is 0.01% to 10%.

11. The contact lens product of claim 1 , wherein the composition for manufacturing the hydrogel further comprises ethylene glycol dimethacrylate, glycerol and 1,1,1-trimethylol propane trimethacrylate;

wherein the weight percentage concentration of the 2-hydroxyethyl methacrylate in the composition for manufacturing the hydrogel is 40% to 96%, the weight percentage concentration of the methacrylic acid in the composition for manufacturing the hydrogel is 0.1% to 2%, a weight percentage concentration of the ethylene glycol dimethacrylate in the composition for manufacturing the hydrogel is 0.1% to 2%, a weight percentage concentration of the glycerol in the composition for manufacturing the hydrogel is 1% to 20%, and a weight percentage concentration of the 1,1,1-trimethylol propane trimethacrylate in the composition for manufacturing the hydrogel is 0.1% to 2%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2020
From: LIN, EN-PING; CHEN, WEI-YUAN; TENG, CHUN-HUNG
To: LARGAN MEDICAL CO., LTD.
Reel/Frame 053392/0312 →
Priority Claims (2)
TW 104130460 · Sep 15, 2015 · national
TW 104135628 · Oct 29, 2015 · national
Continuity (3)
Continuation 16528775 · Aug 1, 2019
Continuation 15251007 · Aug 30, 2016
Related Publication 20200363656A1 · Nov 19, 2020